Education Session
405 - Driving Improvement for Bioprocessing Operations
10 November 14.15-17.15
ISPE CEUs: 0.25
Tracks: SurvivalProductFacilitiesProductionQuality
Sponsored by the ISPE Product Process Development (PPD) Community of Practice
Pharma continues to face challenges and the need for process improvements in operations. This session will address opportunities such as:
- Understanding the key concepts of facility design that impact pure cultures
- Improving the operation of existing bioprocess facilities to avoid contamination
- Managing an effective investigation of process contamination when it does happen
How you will Benefit
At the end of this session, participants will be able to:
- More effectively and efficiently control bioprocessing operations
- Avoid foreign growth in bioprocess operations
- Conduct meaningful investigations
Who Should Attend
Engineers, quality control representatives, and development chemists who are involved in operations or process development for bioprocessing of pharma products
ISPE Communities of Practice (COPs)
Biotech and PPD
View the ISPE Community of Practice (COP) Guide
Session Leaders
- Ryan Schad, P.E., Mgr Bioprocess Dev Pilot Plant, Eli Lilly & Co USA
- Cheryl Tucker, Alliance Management, Eli Lilly & Co. USA
Session Presenters
- Kawa Chiu, Associate Director, Manufacturing, Genentech USA
- Jens Christensen, Sr Research Biochemical Engineer, Merck & Co Inc USA
- Christopher Holmes, Eli Lilly & Co USA
